Zobrazeno 1 - 10
of 21
pro vyhledávání: '"S. N. C. Sridhar"'
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background As per the recent statistical reports of World Health Organisation (WHO), 13% of total global population is obese. Orlistat remains to be the only drug approved for the long term treatment of obesity. Recent findings highlighted s
Externí odkaz:
https://doaj.org/article/afc5948fe3db441a9283dae06638548d
Publikováno v:
New Journal of Chemistry. 44:12355-12369
A novel series of 21 indolyl oxoacetamide analogues was designed based on the natural product lead conophylline, and evaluated for their pancreatic lipase inhibitory activity using porcine pancreatic lipase (Type II). Analogues 12c and 12b exhibited
Autor:
S. N. C, Sridhar, Sengupta, Pracheta, Palawat, Saksham, P. S., Dileep, George, Ginson, Paul, Atish T.
Publikováno v:
Journal of Biomolecular Structure & Dynamics; Nov2022, Vol. 40 Issue 19, p9530-9542, 13p
Autor:
Rawat, Viral, Tiwari, Sona, Khanna, Shweta, Gupta, Umang, S. N. C., Sridhar, Yadav, Dharmendra K., Kaul, Grace, Akhir, Abdul, Saxena, Deepanshi, Matheshwaran, Saravanan, Chopra, Sidharth, Allimuthu, Dharmaraja
Publikováno v:
Chemical Communications; 10/25/2022, Vol. 58 Issue 83, p11669-11672, 4p
Autor:
S. N. C, Sridhar, Sengupta, Pracheta, Palawat, Saksham, P. S., Dileep, George, Ginson, Paul, Atish T.
Publikováno v:
Journal of Biomolecular Structure and Dynamics; November 2022, Vol. 40 Issue: 19 p9530-9542, 13p
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 17, Iss 1, Pp 1-8 (2017)
BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine
Background As per the recent statistical reports of World Health Organisation (WHO), 13% of total global population is obese. Orlistat remains to be the only drug approved for the long term treatment of obesity. Recent findings highlighted severe adv
Publikováno v:
Medicinal Chemistry Research. 26:1268-1278
Obesity is the major leading cause of global mortality among metabolic disorders. Orlistat, a pancreatic lipase inhibitor, is the only approved drug of choice for the long term treatment of obesity. However, recent findings reported severe adverse ef
Autor:
George Ginson, Mukund P. Tantak, P.O. Venkataramana Reddy, S. N. C. Sridhar, Dalip Kumar, Atish T. Paul
Publikováno v:
Bioorganic & Medicinal Chemistry. 25:609-620
A series of twenty four 2-(carbazol-3-yl)-2-oxoacetamide analogues were synthesized, characterized and evaluated for their pancreatic lipase (PL) inhibitory activity. Porcine PL was used against 4-nitrophenyl butyrate (method A) and tributyrin (metho
Publikováno v:
Natural Bio-active Compounds ISBN: 9789811371530
Obesity is a multifactorial metabolic disorder, majorly caused due to high-fat diet associated with decline in physical activity. Recent decades have seen a rapid upsurge in the obese population with over 650 million obese adults worldwide, as indica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d8232e79cd4e4655117a8dc25921543
https://doi.org/10.1007/978-981-13-7154-7_6
https://doi.org/10.1007/978-981-13-7154-7_6
Publikováno v:
Bioorganic chemistry. 85
A series of eighteen indole glyoxylamide analogues were synthesized, characterized and evaluated for their pancreatic lipase inhibitory activity. Porcine pancreatic lipase (Type II) was used with 4-nitrophenyl butyrate (as substrate) for the in vitro